Ari Hakimian
Hematology & Oncology · Park Ridge, ILNPI 1447888276
Payments from drug & device makers
Across 6 payments — averaging $83,356 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$500K
- Rigel Pharmaceuticals, Inc.$43
- Angiodynamics, Inc.$40
- Stemline Therapeutics Inc.$26
- E.r. Squibb & Sons, L.L.C.$25
What the payments were for
- Food & beverage$134100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 1 | $500,000 |
| Rigel Pharmaceuticals, Inc. | 2 | $43 |
| Angiodynamics, Inc. | 1 | $40 |
| Stemline Therapeutics Inc. | 1 | $26 |
| E.r. Squibb & Sons, L.L.C. | 1 | $25 |
How this compares
$500,134 in reported general payments places this provider in the 80th percentile of 580 hematology & oncology providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $7,098 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Park Ridge
- Sigrun HallmeyerPark Ridge$2M
- Richard SchilskyBurr Ridge$87.1M
- Edwin PosadasBurr Ridge$70.9M
- Oana DanciuChicago$23.2M
- Shuo MaChicago$20.5M
- Olwen HahnChicago$11.9M
- Christine BestvinaChicago$11.3M
- Russell SzmulewitzChicago$9.8M
- Randy SweisChicago$9.4M
- Hedy KindlerChicago$8.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.